Detalles de la búsqueda
1.
Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study.
J Psychoactive Drugs
; 44(5): 398-409, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23457891
2.
Addiction Treatment in America: After Money or Aftercare?
J Reward Defic Syndr
; 1(3): 87-94, 2015 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26835513
3.
Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Postgrad Med
; 122(6): 188-213, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21084795
Resultados
1 -
3
de 3
1
Próxima >
>>